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In this issue of Immunity, Irving et al. (2012) show that protein kinaseR (PKR) regulates the cytoskeleton via an
interaction with gelsolin. This alternative role for PKR prevents penetration of virions into the cell.Over the past ten years, the field of innate
immunity has made substantial progress
in better understanding how the host
recognizes and responds to viruses. It is
now evident that this is accomplished by
the collaboration of certain Toll-like
receptors, which monitor the endosomal
compartments of cells for the presence
of viral nucleic acids, and cytosol viral
sensors such as RIG-I andMDA-5. Down-
stream of these, and of major importance
to anti-viral immunity, is the production of
interferons (IFNs), which have potent
antiviral activity and act through the upre-
gulation of a complex network of IFN-
stimulated genes. Additionally, engage-
ment of receptors such as AIM2 can result
in the activation of caspase-1 and pro-
duction of the mature form of the proin-
flammatory cytokines IL-1b and IL-18, as
well as induction of a form of defensive
cell death termed ‘‘pyroptosis.’’ Together,
these classic pattern recognition recep-
tors (PRRs) trigger immune signaling
pathways that make a vital contribution
to antiviral immunity.
However, although these PRR-depen-
dent pathways are of the utmost impor-
tance in protecting from viruses, the
reality is that they are only triggered after
the fact—when the sanctity of the cell
has already been breached. A preferable
strategy would surely be for the host to
simply prevent the invasion of viruses in
the first place. An emerging paradigm in
antiviral immunity suggest that this is the
case and points to an important role of
factors that act primarily to prevent
viruses from accessing the cytosol and
usurping the host machinery required for
their replication. Indeed, it is now
apparent that such factors can afford
a significant advantage to the host and
that there are strong evolutionary pres-
sures to maintain such proteins or to favor
mutant alleles that have these restrictiveproperties. One of the first examples of
this was the discovery of restrictive alleles
of the HIV coreceptors CCR5 and CCR2
that protect from infection andwere found
to offer a major advantage in areas where
HIV is endemic (Kostrikis et al., 1998).
Similarly, studies of New World monkeys
found that simian TRIM5a, but not human
TRIM5a, protected against HIV by accel-
erating the uncoating of the virus (Strem-
lau et al., 2004). More recently, the
IFN-induced transmembrane proteins
were identified as a new family of antiviral
molecules that protect against a number
of viruses, particularly those that enter
via acidic endolysosomal compartments
(Brass et al., 2009). Thus, in a manner
analogous to the epithelial barriers that
protect the organism from pathogen inva-
sion, there appear to also be cell autono-
mous barriers that restrict viral entry.
In this issue of Immunity, Irving et al.
(2012) describe a mechanism of resis-
tance to viral infection that is active under
basal conditions and increased in
response to interferon. This mechanism
of immune resistance involves the innate
immune effector protein kinase R (PKR),
which inhibits the cytoskeleton, blocking
potential actin-dependent routes of viral
entry (Figure 1). They observed that cells
from PKR-deficient mice have an altered
cytoskeleton, with less filamentous actin
and more active membrane processes,
resulting in increased endocytosis. A
search for PKR-binding proteins found
gelsolin, an actin binding protein that
catalyzes the actin cleavage and nucle-
ation required for cytoskeletal rearrange-
ments in lammelopodia extension and
retraction, as well as particle uptake.
Notably, PKR binding inhibited the ability
of gelsolin to bind and sever actin fila-
ments in both in vitro and in vivo assays.
From these observations, the authors
hypothesized that PKR-mediated inhibi-Immunitytion of gelsolin normally serves to inhibit
entry of viral particles in the basal state.
Supporting this theory, silencing of gelso-
lin reduced viral entry and infection into
cells, whereas deletion of PKR increased
infection. Furthermore, knockdown of
gelsolin in mice reduced adenovirus
infection. These results therefore add
regulation of viral entry to the already es-
tablished functions of PKR in inhibiting
viral and host protein translation and
promoting immune responses. Curiously,
the interaction of PKR and gelsolin
occurred only with inactive PKR, whereas
PKR’s other antiviral roles require PKR
activation by binding double-stranded
RNA. Confirming this process, Irving
et al. (2012) activated PKR by the viral nu-
cleic acid mimic polyI:polyC and showed
that this activation released gelsolin inhi-
bition, increasing membrane ruffling.
Thus, once an individual cell is infected
this mechanism is no longer active and
the cells become permissive for infection.
How does this work during an active
infection and what advantage might it
have for the host? An important clue to
answering this is the fact that transcrip-
tion of PKR is regulated by IFN, which
both increased PKR expression and the
amounts of F actin in the cell. Therefore,
because PKR is upregulated by IFN, it
would be predicted that the systemic anti-
viral response might increase the cell-
autonomous resistance of bystander
uninfected cells, and thus acts to limit viral
spread. Although this hypothesis is
a logical extension from this work, exactly
how effective this mechanism of basal
defense is during the systemic antiviral
immune responses remains to be fully
defined and will require further and more
in depth in vivo studies.
Placing these findings in their broader
context, it is well recognized that patho-



















Figure 1. PKR Prevents Viral Entry
Inactive PKR binds gelsolin, inhibiting gelsolin-mediated actin cleavage and nucleation, and preventing
cytoskeletal rearrangements required for viral entry. This mechanism of cellular resistance is reinforced
by interferon (IFN) signaling, which increases expression of PKR. However, following infectionwith viruses,
PKR is activated by double stranded viral RNA. This releases gelsolin, which can promote actin reorgani-
zation, membrane ruffling and endocytosis. Active PKR then takes on its ‘‘classical’’ role in viral defense,
inhibiting protein translation and enhancing pattern recognition receptor (PRR)-mediated immune
responses.
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Previewsliberation of virulence factors thatmanipu-
late it to their advantage and for their own
gain (Aktories et al., 2011). As a mecha-
nism of counterdefense it is also clear,
from this work and the work of others,
that the cytoskeleton, their binding
proteins, and their regulators can play
unusual and unexpected roles immune
defense. An interesting example of how
the cytoskeleton participates in resistance
has been suggested from work in plants,
which indicates that the cytoskeleton is
not justapassivebarrierbut isa ‘‘guarded’’
structure. In this guard hypothesis the
integrity of certain key cellular processes,
such as the cytoskeleton, are monitored
and it is proposed that their disruption by
pathogens alerts the host and triggers
a defense response (Jones and Dangl,
2006). Although described initially in
plants, recent work in model organisms
and mammals support the idea that the
cytoskeleton and its regulators are also
actively monitored in metazoans (Boyer
et al., 2011; Melo and Ruvkun, 2012). But
how common are fortification strategies
such as that described by Irving et al. as
a mechanism of defense? Intriguingly, re-696 Immunity 36, May 25, 2012 ª2012 Elsevisisting pathogen entry by reinforcement
of the cytoskeleton may also be a widely
conserved mechanism of resistance.
Again, work in plants describes a concep-
tually similar and highly effective defense
strategy known as ‘‘penetration resis-
tance’’ (Hardham et al., 2007), in which
cells modify and reorient their actin cyto-
skeleton in response to attempted pene-
tration by microbes. This strengthens
the cell wall at the point of attachment
and directs the localized secretion of cell
wall components to reinforce the barrier
and antimicrobial compounds to destroy
invading pathogens. This defense path-
way occurs independently of PRR-medi-
ated signals and can be induced solely
by applying pressure to the plant cell
wall. Together, these examples illustrate
the complex interplay of the cytoskeleton
and its regulators with the host defense
machinery and indicate that this intricate
and essential network within the cell can
act as both an effector and initiator of
host defense.
The identification of PKR as a new
member of the growing family of resis-
tance genes and the role of the regulatorser Inc.of the cytoskeleton in this process illus-
trate how resistance can be achieved
through very diverse and unusual mecha-
nisms. This work by Irving et al. also
serves to remind us of the importance
of considering non-PRR-based host
defenses against microbes, given that
they are likely to be critical components
of basal immunity, that are active even in
the unprimed state. Such resistance
factors may also be of particular value
when designing strategies to increase
the ability of normal immunocompetent
individuals to fight infection because their
expression is usually not detrimental to
the host and they can be upregulated
without having a negative impact on
immunity or significant fitness costs.
This is in contrast with the expression or
induction of conventional immune res-
ponse pathways, when overexpression
is often associated with uncontrolled
inflammation and immunopathology.
Therefore, the search should be on to
identify other factors like PKR and gelsolin
with roles in preventing infection because
they are likely to offer novel strategies that
could be manipulated to augment immu-
nity and used to engineer resistance to
infection.
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